Treatment Registry
TR-0377 ActiveRecorded September 2, 2026Last verified September 3, 2026

Compounded tirzepatide

Sold by HealthRX · Injection, vial · every compounded tirzepatide record

What you actually pay

Per month

$209

Medication · 3-month plan$209

Added from the figures recorded below.

Price

TermPer monthCharged today
3-month planAdvertised

Compounded Tirzepatide Once-weekly injection · Dual-incretin Dual-incretin therapy. Average 21% body-weight loss at 72 weeks in pivotal phase-3 trial. Compounded at a licensed 503A pharmacy. FROM $209 /mo (3-month plan) · as low as $179/mo on 12-month

source, read September 2, 2026

Per month$209Charged today$209
12-month plan

Compounded Tirzepatide Once-weekly injection · Dual-incretin Dual-incretin therapy. Average 21% body-weight loss at 72 weeks in pivotal phase-3 trial. Compounded at a licensed 503A pharmacy. FROM $209 /mo (3-month plan) · as low as $179/mo on 12-month

source, read September 2, 2026

Per month$179Charged today$179
Enroll with HealthRX

This is a paid link. If you enroll through it, Treatment Registry may earn a commission. It does not change what we record, and it does not change the price you pay.

History

One reading so far. A price history appears here after the next verification pass.

  • September 2, 2026Entry added to the register

Sourcing and terms

StatesAll 50 states
MembershipNone. “There are no separate visit fees or membership fees.”
Consult feeNone. “There are no separate visit fees or membership fees.”

Not yet checked: pharmacy, prescriber and cancellation.

Recorded from healthrx.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2, 2026HealthRX charges the same whatever your dose: “Same price at every dose.” Both plan prices are per month, and the page never says the term is prepaid, so the amount recorded as charged today is one month rather than the whole plan.
  2. 2. September 2, 2026HealthRX is a different company from HealthiCare, which is also in this register at healthicare.com. Similar names, separate businesses.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0377
Readings
2

Related records

What else HealthRX sells

All HealthRX programs and terms

Compounded tirzepatide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 307 records of the same molecule.

Side by side

Cite this entry

Treatment Registry. (2026). HealthRX compounded tirzepatide (TR-0377). Last verified September 3, 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0377

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.